0 Evaluaciones
ID

12417

Descripción

DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury; ODM derived from: https://clinicaltrials.gov/show/NCT02110303

Link

https://clinicaltrials.gov/show/NCT02110303

Palabras clave

Versiones (1)
  1. 17/11/15 17/11/15 -
Subido en

17 de noviembre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Eligibility Coronary Artery Disease NCT02110303

    Inglés

    Eligibility Coronary Artery Disease NCT02110303

    1 formularios  
    Inclusion Criteria
    Descripción

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    patients aged 40 years with angiographically proven multivessel coronary artery disease defined as at least two major epicardial vessels with any combination of either (a) >50% luminal stenosis, or (b) previous revascularization (percutaneous coronary intervention or coronary artery bypass graft surgery).
    Descripción

    Multi vessel coronary artery disease

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1299432
    provision of informed consent prior to any study specific procedures
    Descripción

    Informed Consent

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Descripción

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    an acute coronary syndrome within the last 12 months
    Descripción

    Acute Coronary Syndrome

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0948089
    an indication for dual anti-platelet therapy, such as drug eluting stent
    Descripción

    Anti-platelet drug therapy

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C2963157
    inability to take aspirin
    Descripción

    Inability to take aspirin

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0004057
    receiving thienopyridine therapy such as clopidogrel or prasugrel
    Descripción

    Thienopyridine therapy

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1120149
    percutaneous coronary intervention or coronary artery bypass graft surgery within the last 3 months
    Descripción

    Percutaneous coronary intervention

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1532338
    UMLS CUI [2]
    C0010055
    inability or unwilling to give informed consent
    Descripción

    Informed Consent

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    woman with child-bearing potential and who are breastfeeding will not be enrolled into the trial (woman who have experienced menarche, are pre-menopausal, have not been sterilised or who are currently pregnant)
    Descripción

    Child-bearing potential

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1960468
    known hypersensitivity to ticagrelor or one of its excipients
    Descripción

    Hypersensitivity

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C1999375
    active pathological bleeding or bleeding diathesis
    Descripción

    Pathological bleeding

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0005779
    significant thrombocytopenia: <100 x 10^9 /l
    Descripción

    Thrombocytopenia

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0040034
    history of intracranial haemorrhage
    Descripción

    Intracranial Hemorrhages

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0151699
    moderate to severe liver impairment (child's grade b or c)
    Descripción

    Liver impairment

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0023895
    maintenance therapy with strong cytochrome p450 3a4 (cyp3a4) inhibitors, such as ketoconazole, nefazodone, ritonavir, indinavir, atazanavir, or clarithromycin
    Descripción

    Therapy with strong cytochrome p450 3a4 (cyp3a4) inhibitors

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C3830624
    major intercurrent illness or life expectancy <1 year
    Descripción

    Intercurrent illness

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C3640977
    UMLS CUI [2]
    C0023671
    renal dysfunction (egfr ≤30 ml/min/1.73 m2)
    Descripción

    Renal dysfunction

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C3279454
    contraindication to iodinated contrast agents
    Descripción

    Contrast agents

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0009924
    planned coronary revascularization or major non-cardiac surgery in the next 12 months
    Descripción

    Coronary revascularisation or major non-cardiac surgery

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0877341
    UMLS CUI [2]
    C0543467
    maintenance therapy with simvastatin at doses greater than 40mg daily
    Descripción

    Simvastatin therapy

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0074554
    receiving oral anticoagulants including warfarin, rivaroxaban, dabigatran or apixaban.
    Descripción

    Receiving oral anticoagulants

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0354604
    Volver a la parte superior de la página

    Similar models

    Eligibility Coronary Artery Disease NCT02110303

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Multi vessel coronary artery disease
    Item
    patients aged 40 years with angiographically proven multivessel coronary artery disease defined as at least two major epicardial vessels with any combination of either (a) >50% luminal stenosis, or (b) previous revascularization (percutaneous coronary intervention or coronary artery bypass graft surgery).
    boolean
    C1299432 (UMLS CUI [1])
    Informed Consent
    Item
    provision of informed consent prior to any study specific procedures
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Acute Coronary Syndrome
    Item
    an acute coronary syndrome within the last 12 months
    boolean
    C0948089 (UMLS CUI [1])
    Anti-platelet drug therapy
    Item
    an indication for dual anti-platelet therapy, such as drug eluting stent
    boolean
    C2963157 (UMLS CUI [1])
    Inability to take aspirin
    Item
    inability to take aspirin
    boolean
    C0004057 (UMLS CUI [1])
    Thienopyridine therapy
    Item
    receiving thienopyridine therapy such as clopidogrel or prasugrel
    boolean
    C1120149 (UMLS CUI [1])
    Percutaneous coronary intervention
    Item
    percutaneous coronary intervention or coronary artery bypass graft surgery within the last 3 months
    boolean
    C1532338 (UMLS CUI [1])
    C0010055 (UMLS CUI [2])
    Informed Consent
    Item
    inability or unwilling to give informed consent
    boolean
    C0021430 (UMLS CUI [1])
    Child-bearing potential
    Item
    woman with child-bearing potential and who are breastfeeding will not be enrolled into the trial (woman who have experienced menarche, are pre-menopausal, have not been sterilised or who are currently pregnant)
    boolean
    C1960468 (UMLS CUI [1])
    Hypersensitivity
    Item
    known hypersensitivity to ticagrelor or one of its excipients
    boolean
    C0020517 (UMLS CUI [1,1])
    C1999375 (UMLS CUI [1,2])
    Pathological bleeding
    Item
    active pathological bleeding or bleeding diathesis
    boolean
    C0005779 (UMLS CUI [1])
    Thrombocytopenia
    Item
    significant thrombocytopenia: <100 x 10^9 /l
    boolean
    C0040034 (UMLS CUI [1])
    Intracranial Hemorrhages
    Item
    history of intracranial haemorrhage
    boolean
    C0151699 (UMLS CUI [1])
    Liver impairment
    Item
    moderate to severe liver impairment (child's grade b or c)
    boolean
    C0023895 (UMLS CUI [1])
    Therapy with strong cytochrome p450 3a4 (cyp3a4) inhibitors
    Item
    maintenance therapy with strong cytochrome p450 3a4 (cyp3a4) inhibitors, such as ketoconazole, nefazodone, ritonavir, indinavir, atazanavir, or clarithromycin
    boolean
    C3830624 (UMLS CUI [1])
    Intercurrent illness
    Item
    major intercurrent illness or life expectancy <1 year
    boolean
    C3640977 (UMLS CUI [1])
    C0023671 (UMLS CUI [2])
    Renal dysfunction
    Item
    renal dysfunction (egfr ≤30 ml/min/1.73 m2)
    boolean
    C3279454 (UMLS CUI [1])
    Contrast agents
    Item
    contraindication to iodinated contrast agents
    boolean
    C0009924 (UMLS CUI [1])
    Coronary revascularisation or major non-cardiac surgery
    Item
    planned coronary revascularization or major non-cardiac surgery in the next 12 months
    boolean
    C0877341 (UMLS CUI [1])
    C0543467 (UMLS CUI [2])
    Simvastatin therapy
    Item
    maintenance therapy with simvastatin at doses greater than 40mg daily
    boolean
    C0074554 (UMLS CUI [1])
    Receiving oral anticoagulants
    Item
    receiving oral anticoagulants including warfarin, rivaroxaban, dabigatran or apixaban.
    boolean
    C0354604 (UMLS CUI [1])
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial